Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?

Bozkaya Y., Ozdemir N. Y., Sezer S., Kostek O., Demirci N. S., Yazici O., ...Daha Fazla

CANCER BIOMARKERS, cilt.22, sa.1, ss.143-149, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.3233/cbm-171119
  • Dergi Adı: CANCER BIOMARKERS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.143-149
  • Anahtar Kelimeler: Modified DCF, locally advanced gastric cancer, neoadjuvant chemotherapy, survivin, predictive, ANTI-APOPTOSIS GENE, MESSENGER-RNA, FAVORABLE PROGNOSIS, CISPLATIN TREATMENT, ESOPHAGEAL CANCER, POTENTIAL ROLE, ASSOCIATION, CARCINOMA, THERAPY, PROLIFERATION
  • Gazi Üniversitesi Adresli: Hayır

Özet

BACKGROUND: The potential prognostic value of survivin is variably reported depending on the gastric cancer.